Literature DB >> 35060088

Possible role of arginase 1 positive microglia on depressive/anxiety-like behaviors in atopic dermatitis mouse model.

Bohyun Yang1, Jae-Sang Ryu2, Chan Rim1, Jung U Shin3, Min-Soo Kwon4.   

Abstract

Atopic dermatitis (AD) and mood disorder comorbidities are typical, but the exact mechanism underlying their interplay has not been clarified. In this study, we aimed to identify the possible mechanisms of anxiety/depressive-like behaviors observed in AD, focusing on microglia. AD was induced by Dermatophagoides farinae body extract (Dfb) in NC/Nga mice and anxiety/depressive-like behaviors were analyzed by behavioral assessments such as open field test (OFT), tail suspension test (TST), sucrose preference test (SPT), and social interaction. As clinical symptoms of AD induced, anxiety/depressive-like behaviors were increased in the OFT and TST and serum glucocorticoid was elevated. AD mice showed an increased mRNA expression of interleukin-4 (IL-4) in lymph nodes but decreased arginase 1 (Arg1) mRNA expression without a change of IL-4 in the hippocampus. In addition, AD mice showed microglia with a shortened branch of de-ramified form and astrocytes with longer processes and decreased branching in the hippocampus, especially in the dentate gyrus (DG). The immunofluorescence study of the DG confirmed that Arg1 reduction was associated with microglia, but not astrocytes. Furthermore, glucocorticoid receptor reduction, increased 5-HT1AR, reduced phosphorylated cAMP response element-binding protein (pCREB), and brain-derived neurotrophic factor (BDNF) expression were identified in the hippocampus of AD mice. Notably, an immunofluorescence study confirmed that pCREB was decreased in the DG of AD mice. Collectively, our data suggest that the reduced Arg1 positive microglia might contribute to anxiety/depressive-like behaviors via pCREB/BDNF reduction in AD.
© 2022. The Pharmaceutical Society of Korea.

Entities:  

Keywords:  Anxiety; Arginase 1; Atopic dermatitis; Depression; Microglia

Mesh:

Substances:

Year:  2022        PMID: 35060088     DOI: 10.1007/s12272-022-01369-3

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  51 in total

Review 1.  Cytokines, stress, and depressive illness.

Authors:  H Anisman; Z Merali
Journal:  Brain Behav Immun       Date:  2002-10       Impact factor: 7.217

2.  Impairment of skin barrier function in NC/Nga Tnd mice as a possible model for atopic dermatitis.

Authors:  A Aioi; H Tonogaito; H Suto; K Hamada; C R Ra; H Ogawa; H Maibach; H Matsuda
Journal:  Br J Dermatol       Date:  2001-01       Impact factor: 9.302

Review 3.  Microglial immune checkpoint mechanisms.

Authors:  Aleksandra Deczkowska; Ido Amit; Michal Schwartz
Journal:  Nat Neurosci       Date:  2018-05-07       Impact factor: 24.884

4.  Impact of atopic dermatitis on quality of life in adults: a systematic review and meta-analysis.

Authors:  Gurkiran Birdi; Richard Cooke; Rebecca C Knibb
Journal:  Int J Dermatol       Date:  2020-01-13       Impact factor: 2.736

5.  Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication.

Authors:  B Chen; D Dowlatshahi; G M MacQueen; J F Wang; L T Young
Journal:  Biol Psychiatry       Date:  2001-08-15       Impact factor: 13.382

6.  Risk of developing major depressive disorder and anxiety disorders among adolescents and adults with atopic dermatitis: a nationwide longitudinal study.

Authors:  Chih-Ming Cheng; Ju-Wei Hsu; Kai-Lin Huang; Ya-Mei Bai; Tung-Ping Su; Cheng-Ta Li; Albert C Yang; Wen-Han Chang; Tzeng-Ji Chen; Shih-Jen Tsai; Mu-Hong Chen
Journal:  J Affect Disord       Date:  2015-03-05       Impact factor: 4.839

7.  Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy.

Authors:  Megumi Adachi; Michel Barrot; Anita E Autry; David Theobald; Lisa M Monteggia
Journal:  Biol Psychiatry       Date:  2007-11-05       Impact factor: 13.382

8.  Brain-derived neurotrophic factor and its clinical implications.

Authors:  Siresha Bathina; Undurti N Das
Journal:  Arch Med Sci       Date:  2015-12-11       Impact factor: 3.318

9.  Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis: A Systematic Review and Network Meta-analysis.

Authors:  Aaron M Drucker; Alexandra G Ellis; Michal Bohdanowicz; Soudeh Mashayekhi; Zenas Z N Yiu; Bram Rochwerg; Sonya Di Giorgio; Bernd W M Arents; Tim Burton; Phyllis I Spuls; Denise Küster; Doreen Siegels; Jochen Schmitt; Carsten Flohr
Journal:  JAMA Dermatol       Date:  2020-06-01       Impact factor: 10.282

View more
  1 in total

1.  Microglia involvement in sex-dependent behaviors and schizophrenia occurrence in offspring with maternal dexamethasone exposure.

Authors:  Chan Rim; Hyun-Sun Park; Min-Jung You; Bohyun Yang; Hui-Ju Kim; Soyoung Sung; Min-Soo Kwon
Journal:  Schizophrenia (Heidelb)       Date:  2022-09-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.